Lakefront Biotherapeutics | GLPG - Trade Creditors


Lakefront Biotherapeutics reported EUR66.35M in Trade Creditors for its fiscal quarter ending in June of 2026.





Trade Creditors Change Date
argenx SE USD 719M 164.73M Jun/2026
AstraZeneca USD 22.89B 388M Jun/2026
Biogen USD 403.9M 45.4M Jun/2026
Genmab DKK 116M 110M Jun/2026
Gilead Sciences USD 645M 70M Mar/2026
GlaxoSmithKline GBP 14.34B 7M Jun/2026
GRIFOLS EUR 1B 160M Jun/2026
Hikma Pharmaceutical USD 715M 104M Dec/2025
Incyte USD 1.39B 1.16B Jun/2026
Merck EUR 2.07B 61M Jun/2026
Neurocrine Biosciences USD 691.3M 145.8M Mar/2026
Novartis USD 4.26B 64M Jun/2026
Roche Holding CHF 5.54B 237M Jun/2026
Sanofi EUR 23.6B 888M Jun/2026
UCB EUR 4.04B 755M Dec/2025
Vertex Pharmaceuticals USD 3.61B 135M Jun/2026